Cargando…

Metformin Treatment Is Associated with a Decreased Risk of Nonproliferative Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study

PURPOSE: To assess the relationship between metformin use and the severity of diabetic retinopathy (DR) in patients with type 2 diabetes mellitus (T2DM) and to investigate the effect of metformin dosage on reducing the incidence of DR. METHODS: The study population included patients with newly diagn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Yu-Pei, Wu, Chien-Tung, Lin, Jiun-Lu, Hsiung, Chao A., Liu, Hsiao Yu, Lai, Jung-Nien, Yang, Chen-Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189314/ https://www.ncbi.nlm.nih.gov/pubmed/32377525 http://dx.doi.org/10.1155/2020/9161039

Ejemplares similares

Decreased Retinal Thickness in Type 1 Diabetic Children with Signs of Nonproliferative Diabetic Retinopathy
por: Ruiz-Ocaña, P., et al.
Publicado: (2018)

Ocular Rigidity and Outflow Facility in Nonproliferative Diabetic Retinopathy
por: Panagiotoglou, Theonitsa, et al.
Publicado: (2015)

Associations between Macular OCT Angiography and Nonproliferative Diabetic Retinopathy in Young Patients with Type 1 Diabetes Mellitus
por: Veiby, Nina C. B. B., et al.
Publicado: (2020)

Serum TNF-Alpha Level Predicts Nonproliferative Diabetic Retinopathy in Children
por: Zorena, Katarzyna, et al.
Publicado: (2007)

Intervention with vitamins in patients with nonproliferative diabetic retinopathy: a pilot study
por: Smolek, Michael K, et al.
Publicado: (2013)

Optical Coherence Tomography Angiography Contributions in Classification of Nonproliferative Diabetic Retinopathy
por: Kasumovic, Armin, et al.
Publicado: (2020)

Determining Risk Factors That Affect Progression in Patients with Nonproliferative Diabetic Retinopathy
por: Chen, Dalbert J., et al.
Publicado: (2021)

Therapeutic Effect of Abelmoschus manihot on Type 2 Diabetic Nonproliferative Retinopathy and the Involvement of VEGF
por: Zhao, Yue, et al.
Publicado: (2020)

Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy
por: Bahr, Tyler A., et al.
Publicado: (2023)

Different Risk Profiles for Progression of Nonproliferative Diabetic Retinopathy: A 2-Year Study
por: Marques, Inês P., et al.
Publicado: (2022)

Hyperreflective Intraretinal Spots in Diabetics without and with Nonproliferative Diabetic Retinopathy: An In Vivo Study Using Spectral Domain OCT
por: Vujosevic, Stela, et al.
Publicado: (2013)

Assessment of optical coherence tomography angiography and multifocal electroretinography in eyes with and without nonproliferative diabetic retinopathy
por: Srinivasan, Sangeetha, et al.
Publicado: (2021)

Using Ultrawide Field-Directed Optical Coherence Tomography for Differentiating Nonproliferative and Proliferative Diabetic Retinopathy
por: Ashraf, Mohamed, et al.
Publicado: (2023)

Elevated Levels of Plasma IgA Autoantibodies against Oxidized LDL Found in Proliferative Diabetic Retinopathy but Not in Nonproliferative Retinopathy
por: Vavuli, Satu, et al.
Publicado: (2016)

Superficial capillary perfusion on optical coherence tomography angiography differentiates moderate and severe nonproliferative diabetic retinopathy
por: Ong, Janice X., et al.
Publicado: (2020)

Venous beading in two or more quadrants might not be a sensitive grading criterion for severe nonproliferative diabetic retinopathy
por: Chen, Ling, et al.
Publicado: (2018)

Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial
por: Brown, David M., et al.
Publicado: (2021)

Microaneurysm Turnover at the Macula Predicts Risk of Development of Clinically Significant Macular Edema in Persons With Mild Nonproliferative Diabetic Retinopathy
por: Ribeiro, Maria Luisa, et al.
Publicado: (2013)

Compound Danshen Dripping Pill for Treating Nonproliferative Diabetic Retinopathy: A Meta-Analysis of 13 Randomized Controlled Trials
por: Huang, Wenjing, et al.
Publicado: (2017)

The role of NOS2A −954G/C and vascular endothelial growth factor +936C/T polymorphisms in type 2 diabetes mellitus and diabetic nonproliferative retinopathy risk management
por: Porojan, Mihai Dumitru, et al.
Publicado: (2015)

Circulating levels of reactive oxygen species in patients with nonproliferative diabetic retinopathy and the influence of antioxidant supplementation: 6-month follow-up
por: Domanico, Daniela, et al.
Publicado: (2015)

Role of N–epsilon- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus
por: Choudhuri, Subhadip, et al.
Publicado: (2013)

Intravitreal Ranibizumab Alone or in Combination with Calcium Dobesilate for the Treatment of Diabetic Macular Edema in Nonproliferative Diabetic Retinopathy Patients: 12-Month Outcomes of a Retrospective Study
por: Wang, Dongxuan, et al.
Publicado: (2022)

A Nonrandomized Phase 2 Trial of EG-Mirotin, a Novel, First-in-Class, Subcutaneously Deliverable Peptide Drug for Nonproliferative Diabetic Retinopathy
por: Yoo, Seunghoon, et al.
Publicado: (2023)

Abnormally Low or High Ankle-Brachial Index Is Associated With the Development of Diabetic Retinopathy in Type 2 Diabetes Mellitus
por: Lee, Mei-Yueh, et al.
Publicado: (2018)

Abnormally Low or High Ankle-Brachial Index Is Associated with Proliferative Diabetic Retinopathy in Type 2 Diabetic Mellitus Patients
por: Chen, Szu-Chia, et al.
Publicado: (2015)

The underestimated significance of nonproliferative lupus nephritis
por: Kwok, Seung-Ki
Publicado: (2023)

Metformin in Gestational Diabetes Mellitus
por: Reece, Sara Wilson, et al.
Publicado: (2014)

Metformin in gestational diabetes mellitus
por: Tripathi, Reva, et al.
Publicado: (2017)

Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients
por: Tseng, Chin-Hsiao
Publicado: (2018)

Multiple Single Nucleotide Polymorphism Testing Improves the Prediction of Diabetic Retinopathy Risk with Type 2 Diabetes Mellitus
por: Hsiao, Yu-Ting, et al.
Publicado: (2021)

Supplementation with a highly concentrated docosahexaenoic acid plus xanthophyll carotenoid multivitamin in nonproliferative diabetic retinopathy: prospective controlled study of macular function by fundus microperimetry
por: Rodríguez González-Herrero, María Elena, et al.
Publicado: (2018)

Prospective, Single-Center, Six-Month Study of Intravitreal Ranibizumab for Macular Edema with Nonproliferative Diabetic Retinopathy: Effects on Microaneurysm Turnover and Non-Perfused Retinal Area
por: Lee, Seung Joon, et al.
Publicado: (2020)

Metformin and Risk of Hypertension in Taiwanese Patients With Type 2 Diabetes Mellitus
por: Tseng, Chin‐Hsiao
Publicado: (2018)

Metformin and lung cancer risk in patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2017)

Metformin Use and Leukemia Risk in Patients With Type 2 Diabetes Mellitus
por: Tseng, Chin-Hsiao
Publicado: (2020)

Dose–Response Association of Metformin with Parkinson’s Disease Odds in Type 2 Diabetes Mellitus
por: Huang, Kuang-Hua, et al.
Publicado: (2022)

Does myopia decrease the risk of diabetic retinopathy in both type-1 and type-2 diabetes mellitus?
por: Thakur, Swapnil, et al.
Publicado: (2021)

Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2016)

Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5eu09s0l6fq4dqsagj1e82ogh0